Neurodivergent travellers face warning over insurance rules

A sharp rise in holidaymakers declaring autism, ADHD and other neurodivergent conditions on travel insurance forms is prompting renewed warnings that incomplete or unclear medical disclosures can leave travellers without cover when they need it most.

Data shows surge in mental health and neurodivergent declarations

Recent reporting on the UK travel insurance market indicates that medical declarations linked to mental health and neurodivergent conditions have increased significantly over the past two years, with some providers stating that overall holiday medical declarations have more than doubled compared with pre pandemic levels. Industry coverage points to a visible rise in customers disclosing autism and ADHD in particular, reflecting both higher diagnosis rates and greater awareness of the need to tell insurers about long term conditions.

Published guidance from comparison sites and specialist brokers in 2024 and 2025 stresses that any diagnosed mental health condition now typically has to be declared, even if symptoms are well controlled or medication is no longer being taken. That advice increasingly references conditions such as ADHD, autism spectrum conditions, depression and anxiety alongside physical illnesses. One UK broker, for example, updated its July 2026 guidance to emphasise that leaving a diagnosed mental health condition off an application can allow an insurer to treat the policy as if it never existed if a claim is made.

Regulators and official travel advice have also highlighted the broader shift. UK government travel insurance guidance updated in August 2024 reminds travellers that international cover should include existing physical or mental health conditions, including those still under investigation, because some policies may specifically exclude claims linked to undeclared mental health issues. Consumer organisations and patient groups argue that these trends make it more important for neurodivergent travellers to understand exactly what must be disclosed before they buy a policy.

Complex wording leaves neurodivergent travellers exposed

While many policies state in general terms that pre existing medical conditions must be declared, the detailed wording of health questionnaires can be difficult to interpret for people with neurodivergent conditions. Some mainstream UK policy documents reviewed in 2024 and 2025 require customers to contact the insurer if they have ever been diagnosed or treated for certain categories of condition, or if they are awaiting tests or referrals. In several cases, mental health and neurodevelopmental conditions are grouped together with other lifelong or long term diagnoses.

Another common formulation asks whether the customer has any undiagnosed condition or symptoms that are under investigation. Neurodivergent travellers undergoing assessment for possible autism or ADHD have reported that this phrasing makes it unclear whether they must disclose an ongoing diagnostic process, even where no treatment is involved and there is no expectation that the assessment will affect their ability to travel safely. Public discussions on consumer forums and social platforms over the past two years show repeated confusion about whether waiting for a neurodevelopmental assessment is treated in the same way as awaiting investigation for a serious physical illness.

Policy wordings from several European and UK brands published between 2024 and late 2025 explicitly list disabilities or conditions that impair mobility, vision or mental health in their health declaration sections. In some cases, cover is available provided the traveller is accompanied by an appropriate carer if assistance is required. However, these clauses are often written with physical disability in mind, and do not always distinguish clearly between mental illness, neurodevelopmental difference and intellectual disability, leaving scope for differing interpretations at claim stage.

Official guidance emphasises full disclosure but limited clarity

Publicly available advice from governments and health agencies consistently urges travellers to be open with insurers about existing conditions, but offers limited specific direction on neurodivergence. The UK government’s foreign travel insurance guidance advises travellers to buy cover that includes existing mental health conditions, including those still being investigated, and warns that some insurers may exclude treatment related to pre existing mental health issues if these are not declared in advance.

Travel health resources from agencies such as the US Centers for Disease Control and Prevention and national foreign affairs departments focus largely on preparing medical documentation, carrying sufficient medication and checking that policies cover emergency treatment and evacuation. Mental health and cognitive conditions are generally mentioned within broader categories of disability or chronic illness rather than addressed in detail. Australian government advice updated in 2025, for example, notes ongoing concerns about how mental health is treated in travel insurance and recommends that travellers scrutinise mental health exclusions and read consumer buying guides before purchase.

Academic and policy commentary also underlines a wider gap between disability inclusion goals and financial products. Reviews of publicly available evidence on neurodivergent disclosure in travel and employment contexts have found that much of the existing data relates to workplace discrimination rather than insurance, making it difficult to quantify exactly how disclosure requirements and pricing are changing for holiday cover. Analysts caution that isolated examples should not be extrapolated to the entire market, but agree that the direction of travel points toward more detailed questioning and a stronger emphasis on mental health history.

Cost implications and limited specialist options

Available consumer information suggests that declaring a mental health or neurodivergent condition can affect both eligibility and pricing, particularly for travellers with multiple diagnoses or recent changes in treatment. Specialist mental health travel insurance products promoted to UK customers in 2024 and 2025 typically charge higher premiums than basic policies, reflecting the additional cover offered for pre existing conditions and cancellation linked to mental health episodes.

Comparison sites dedicated to pre existing medical conditions report that some mainstream policies still provide no cover at all for claims arising from an undeclared or excluded mental health condition, even where emergency medical treatment is needed overseas. Others offer cover provided the condition has been stable for a specified period, often one or two years, with no change in medication or hospital admission. For neurodivergent travellers, this can create a challenge if medication has recently been adjusted or if support needs are being reassessed.

At the same time, insurers point out in publicly available materials that declaring a condition does not automatically mean a policy will be declined. Some brands state that autism or ADHD which has never forced a traveller to cut short a holiday and does not involve recent hospital treatment may have little or no effect on eligibility or price, provided it is disclosed as requested. However, consumer case studies show that where mental health conditions are combined with other risk factors or recent crises, premiums can rise sharply or cover may only be available from a smaller pool of specialist providers.

What neurodivergent travellers can do before booking

Consumer advocates and official travel advice agree on several practical steps that can help neurodivergent travellers reduce the risk of invalidated cover. First, they recommend obtaining and reading the insurer’s full medical declaration wording rather than relying solely on marketing summaries. Particular attention should be paid to sections titled health declaration or health exclusions, where questions about ever having been diagnosed, awaiting tests or having symptoms under investigation are usually set out in detail.

Second, travellers are encouraged to check whether their condition is likely to be classed as a pre existing medical condition under the policy. Many insurers define this as any condition for which the traveller has experienced symptoms, received treatment or taken prescribed medication within a certain period, commonly the previous two years, or any earlier condition that could reasonably be expected to affect current health. Neurodivergent travellers who are unsure whether a pending assessment or historical diagnosis falls within these definitions are advised to seek clarification directly from the insurer in writing, so that any decision about disclosure is documented.

Finally, travel health guidance recommends arranging cover as soon as a trip is booked rather than waiting until departure. Buying early means that if a change in diagnosis or support needs forces a cancellation before travel, there is a greater chance that costs will be recoverable under the policy. Organisations that support neurodivergent people also stress the importance of carrying a summary of diagnoses, medications and reasonable adjustments when travelling, both to assist medical staff in an emergency and to support any subsequent insurance claim.